Semaglutide has already demonstrated cardiovascular benefits in the SUSTAIN and SELECT trials, giving it an established safety profile for cardiovascular risk reduction
All company claims are attributed to the brand and clearly distinguished from independent research findings
GLP-1 drugs are a class of medications used to treat obesity and type 2 diabetes that include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)
Diabetes Healthcare Professionals Consider Whole Person As diabetes healthcare professionals, we want to carefully consider which medication best matches the people in our care, considering individual values and preferences along with co-conditions including diabetes, cardiorenal metabolic co-conditions, MASH, sleep apnea and weight goals
He works with you every step of the way to help you develop healthy habits that will not only help you lose weight but also maintain it for the future